The special committee has retained Houlihan Lokey China Limited as financial advisor and Kirkland & Ellis as U.S. legal counsel to review a September 16, 2026 non-binding proposal. No decisions have been made, and no definitive offer is assured.
YI · 111, Inc.
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Key stats
- Close
- $2.51
- Open
- $2.82
- Day range
- $2.50–2.82
- 52-week closing range
- $2.51–8.38
- Average volume, 30 days
- 15K
- Short interest
- 13K · 0.1% of shares · 1.0 days
- Short volume, last session
- 26%
- Last earnings
- Dec 31, 2024
- Price history
- Jan 2020 to Nov 2026
Up next
Latest documents
111, Inc.’s Board established a Special Committee of three independent directors to evaluate the preliminary, non-binding proposal letter dated September 16, 2026 and other strategic alternatives; no decisions have been made.
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong SellIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Distribution — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
YI
this stock
111, Inc.
|
$22.08M | -2.0% | -9.0% | — | 0.1% |
|
MCK
Mckesson Corp
|
$122.63B | +29.5% | +3.1% | 27.4 | 1.7% |
|
COR
Cencora, Inc.
|
$65.12B | +1.0% | +9.3% | 25.3 | 1.7% |
|
CAH
Cardinal Health Inc
|
$62.95B | +32.5% | +14.2% | — | 3.3% |
|
HSIC
Henry Schein Inc
|
$9.37B | +12.2% | +5.9% | 23.2 | 8.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Oct 26, 2026
- This year
- 7
The special committee has retained Houlihan Lokey China Limited as financial advisor and Kirkland & Ellis as U.S. legal counsel to review a September 16, 2026 non-binding proposal. No decisions have been made, and no definitive offer is assured.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| YI | -11.9% | -18.2% | -53.5% | -11.9% | -2.0% |
| SPY | -5.5% | -6.3% | -5.6% | -5.3% | +5.0% |
| vs SPY | -6.5% | -12.0% | -47.9% | -6.7% | -6.9% |